- Saturday, April 20, 2024
By: Eastern Eye Staff
ONE of India’s best-known whistleblowers, who exposed dangerous practices in the generic drug industry in 2013, is taking the country’s drugs regulators to court, accusing them of failing to enforce rules on drug safety in the $15 billion industry. Three years ago, Dinesh Thakur exposed how India’s then largest drugmaker and his former employer, Ranbaxy Laboratories, failed to conduct proper safety and quality tests on drugs and lied to regulators about its procedures. He made his name, and almost $48 million as a whistleblower award from the United States, when US regulators fined Ranbaxy $500 million for violating federal drug…
You do not have access to this content. You need to subscribe.
